SCHEMBL5970105

SCHEMBL5970105

CC(C)C(C(=O)O)N1C(=O)C(=Cc2ccccc2)SC1=S

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL2 P10415 5/20 0.80
MEN1 O00255 4/20 0.80
KMT2A Q03164 4/20 0.80
BCL2L1 Q07817 1/20 0.80
MCL1 Q07820 1/20 0.80
BAK1 Q16611 1/20 0.80
MAPT P10636 7/20 0.74
POLB P06746 4/20 0.74
ALDH1A1 P00352 2/20 0.74
LMNA P02545 1/20 0.74
GAA P10253 1/20 0.74
ADAMTS5 Q9UNA0 2/20 0.67
L3MBTL1 Q9Y468 2/20 0.59
KDM4E B2RXH2 1/20 0.59
USP2 O75604 1/20 0.59
CYP3A4 P08684 1/20 0.59
THRB P10828 1/20 0.59
CYP2C9 P11712 1/20 0.59
HPGD P15428 1/20 0.59
ALOX12 P18054 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5970104 1.00 BCL2 (0.80) BCL2MEN1KMT2ABCL2L1MCL1
SCHEMBL13657863 0.93 BCL2 (0.77) BCL2MEN1KMT2ABCL2L1MCL1
SCHEMBL13219035 0.91 BCL2 (0.67) BCL2MEN1KMT2ABCL2L1MCL1
SCHEMBL13982547 0.90 BCL2 (0.80) BCL2MEN1KMT2ABCL2L1MCL1
SCHEMBL17655014 0.90 BCL2 (0.65) BCL2MEN1KMT2ABCL2L1MCL1
SCHEMBL13812532 0.90 BCL2 (0.80) BCL2MEN1KMT2ABCL2L1MCL1
SCHEMBL4264548 0.89 BCL2 (1.00) BCL2MEN1KMT2ABCL2L1MCL1
SCHEMBL14163443 0.89 KMT2A (0.78) BCL2MEN1KMT2ABCL2L1MCL1
SCHEMBL158041 0.89 BCL2 (1.00) BCL2MEN1KMT2ABCL2L1MCL1
SCHEMBL158040 0.89 BCL2 (1.00) BCL2MEN1KMT2ABCL2L1MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060037091-A1 Method for producing hypertrophic scarring animal model for identification of agents for prevention and treatment of human hypertrophic scarring GURTNER GEOFFREY C 2006-02-16 US disclosed